2012
DOI: 10.3390/app2020465
|View full text |Cite
|
Sign up to set email alerts
|

A Dual PET/MR Imaging Nanoprobe: 124I Labeled Gd3N@C80

Abstract: Abstract:The current report describes the development of a dual modality tomographic agent for both positron emission tomography and magnetic resonance imaging (PET/MRI). The dual-modality agent in this study was based on a 124 I (PET) radiolabeled tri-gadolinium endohedral metallofullerene Gd 3 N@C 80 (MRI) nanoprobe platform. The outer surface of the fullerene cage of the Gd 3 N@C 80 metallofullerenes was surface functionalized with carboxyl and hydroxyl groups (f-Gd 3 N@C 80 ) using previously developed pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
24
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 44 publications
(51 reference statements)
0
24
0
Order By: Relevance
“…Another multi-modal imaging platform has been developed by Luo et al for combined positron emission tomography (PET) and MRI. 121 Exohedral addition of 124 I to hydroxylated Gd 3 N@C 80 conferred the PET ability although, as with the X-ray CA of Wharton et al, 85 iodine must be stably attached to the cage to avoid allergic reactions. A lack of iodine uptake in the thyroid gland seemed to suggest good stability of this molecule, giving it promise as a future dual-modal imaging tool.…”
Section: Brachytherapy Chemotherapy and Dual-modal Imagingmentioning
confidence: 99%
“…Another multi-modal imaging platform has been developed by Luo et al for combined positron emission tomography (PET) and MRI. 121 Exohedral addition of 124 I to hydroxylated Gd 3 N@C 80 conferred the PET ability although, as with the X-ray CA of Wharton et al, 85 iodine must be stably attached to the cage to avoid allergic reactions. A lack of iodine uptake in the thyroid gland seemed to suggest good stability of this molecule, giving it promise as a future dual-modal imaging tool.…”
Section: Brachytherapy Chemotherapy and Dual-modal Imagingmentioning
confidence: 99%
“…However, such techniques may have limited signal penetration in vivo and lack the widespread clinical utility observed with more conventional diagnostic imaging modalities. Thus far, there have been only a few reports of SWCNT-based probes for clinically relevant imaging modalities with full-body penetration such as computed tomography (CT), single-photon emission CT, positron emission tomography (PET) and MRI [1517] . Both T1- and T2-weighted SWCNT-based magnetic resonance (MR) CAs have been prepared, frequently through attachment of chelated Gd 3+ or iron oxide on the external surface of the SWCNT material [18, 19] .…”
mentioning
confidence: 99%
“…Therefore, the interest in development and characterization of dual imaging agents is apparent [80]. Recent studies have described the synthesis and initial in vivo imaging of a metallofullerene-based nanoplatform for PET/MRI [73]. This agent design is shown in Figure 2B, and was synthesized through iodination of the Gd 3 N@C 80 species with iodine.…”
Section: Multimodality and Simultaneous Imagingmentioning
confidence: 98%
“…Examples of this include the aforementioned encapsulation of Gd or Gd 3 N for MRI contrast [26,32], Lu 3 N for x-ray contrast [71] and g-emitters for SPECT detection [42]. External ligands have also been added to empty C 60 cages to provide x-ray contrast [47,72] and radiolabeling [46,73].…”
Section: Multimodality and Simultaneous Imagingmentioning
confidence: 99%